COMAC MEDICAL is a seasoned player in the contract research organization (CRO) landscape across Europe and Eurasia. Operating for over 27 years, this Bulgarian-headquartered company is renowned for its full-service clinical trial solutions, spanning from Phase I to Phase IV, and medical device investigations.
Specializing in therapeutic domains like oncology, cardiology, and neurology, the firm's reach extends over 24 countries, handling more than 1500 research studies. Its early phase Clinical Research Unit, boasting the largest and most advanced Phase I Unit in Southeastern Europe, enhances its service quality with cutting-edge facilities in Sofia.
With its last financial boost of €50.00K from EASME in September 2015, COMAC MEDICAL demonstrates its reliance on strategic partnerships to deliver high-impact research solutions, fulfilling their guiding mission of fostering medical innovation.